test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BHCBausch Health Cos Inc
Recent Activity
New Position
0.86%
$12.492M
1.531M shares@ $8.16 avg price
FTREFortrea Hldgs Inc
Recent Activity
New Position
0.63%
$9.159M
457,967 shares@ $20.0 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
New Position
0.63%
$9.109M
124,491 shares@ $73.17 avg price
BHVNBiohaven Ltd
Recent Activity
New Position
0.46%
$6.623M
132,537 shares@ $49.98 avg price
FNAParagon 28 Inc
Recent Activity
New Position
0.35%
$5.005M
749,213 shares@ $6.69 avg price
STAAStaar Surgical Co
Recent Activity
New Position
0.24%
$3.388M
91,199 shares@ $37.16 avg price
ZLABZai Lab Ltd
Recent Activity
New Position
0.23%
$3.264M
135,219 shares@ $24.15 avg price
ZBIOZenas Biopharma Inc
Recent Activity
New Position
0.23%
$3.224M
190,531 shares@ $16.93 avg price
MRVIMaravai Lifesciences Hldgs I
Recent Activity
New Position
0.2%
$2.8M
336,966 shares@ $8.31 avg price
AVTEAerovate Therapeutics Inc
Recent Activity
New Position
0.07%
$1.014M
485,141 shares@ $2.1 avg price